Craft

Alliance Pharma

Stock Price

£0.3

2024-05-10

Market Capitalization

£361.8 M

2023-05-03

Revenue

£167.4 M

FY, 2022

Alliance Pharma Summary

Company Summary

Overview
Alliance's expertise lies in the acquisition and licensing of pharmaceutical and healthcare products and delivering these to patients. Its activities such as manufacturing, warehousing and logistics are outsourced to class leading specialists in these fields.
Type
Public
Status
Active
Founded
1996
HQ
Wiltshire, GB | view all locations
Website
http://alliancepharmaceuticals.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Peter Butterfield

    Peter Butterfield, Chief Executive Officer

    • Stephen Kidner

      Stephen Kidner, Chief Scientific & Operations Officer

      • Janice Timberlake

        Janice Timberlake, Chief People & Infrastructure Officer

        • David Cook

          David Cook, Independent Non-executive Chairman

          LocationsView all

          9 locations detected

          • Wiltshire, England HQ

            United Kingdom

            Bath Rd

          • Cary, NC

            United States

            11000 Regency Pkwy #106

          • Shanghai Shi

            China

            Hua Shan Lu

          • Paris, IDF

            France

            35 Rue d'Artois

          • Düsseldorf, NRW

            Germany

            Niederkasseler Lohweg 175

          • Milano, Lombardia

            Italy

            Viale Francesco Restelli, 5

          and 3 others

          Alliance Pharma Financials

          Summary Financials

          Revenue (H1, 2023)
          £81.4M
          Gross profit (H1, 2023)
          £47.6M
          Net income (H1, 2023)
          £5.1M
          Cash (H1, 2023)
          £26.1M
          EBIT (H1, 2023)
          £12.2M
          Enterprise value
          $460.1M

          Footer menu